Zobrazeno 1 - 10 of 109 pro vyhledávání: '"Coschi CH"'
1
Erratum to "Brief Report: Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (NCT02784171). [Journal of Thoracic Oncology Vol. 18 No. 6: 813-819]".
Autor: Piccirillo MC; Clinical Trials Unit, Istituto Nazionalei Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G. Pascale, Napoli, Italy., Chu Q; Cross Cancer Institute, Edmonton, Alberta, Canada., Bradbury P; University Health Network, Toronto, Ontario, Canada., Tu W; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Coschi CH; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Grosso F; Mesothelioma Unit (FG) & Department of Integrated Activities Research and Innovation (FU), SS. Antonio e Biagio C. Arrigo Hospital, Alessandria, Italy., Florescu M; Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada., Mencoboni M; Oncology Unit ASL 3, Villa Scassi Hospital, Genova, Italy., Goffin JR; Juravinski Cancer Centre, Ontario, Canada., Pagano M; Medical Oncology, Comprehensive Cancer Centre, AUSL Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) of Reggio Emilia, Reggio Emilia, Italy., Ciardiello F; Oncology and Hematology Unit, University of Campania 'Luigi Vanvitelli,' Naples, Italy., Cecere FL; Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituti Fisioterapici Ospitalieri (IFO) Istituto Regina Elena, Rome, Italy., Vincent M; London Regional Cancer Program, London, Ontario, Canada., Ferrara R; Thoracic Oncology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milano, Italy., Dawe DE; Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, Canada., Hao D; Tom Baker Cancer Centre and Cumming School of Medicine, Calgary, Alberta, Canada., Lee CW; British Columbia Cancer Agency, Surrey, British Columbia, Canada., Morabito A; Thoracic Oncology Unit, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G. Pascale, Napoli, Italy., Gridelli C; Oncology Unit, S. Giuseppe Moscati Hospital, Avellino, Italy., Cavanna L; Oncology and Hematology Department, USL Piacenza, Gugliemimo da Saliceto Hospital, Piacenza, Italy., Iqbal M; Allan Blair Cancer Centre, Regina, Saskatchewan, Canada., Blais N; Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada., Leighl NB; University Health Network, Toronto, Ontario, Canada., Wheatley-Price P; Ottawa Hospital Research Institute and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Tsao MS; University Health Network, Toronto, Ontario, Canada., Ugo F; Mesothelioma Unit (FG) & Department of Integrated Activities Research and Innovation (FU), SS. Antonio e Biagio C. Arrigo Hospital, Alessandria, Italy., El-Osta H; Merck & Co, Inc., Rahway, New Jersey., Gargiulo P; Clinical Trials Unit, Istituto Nazionalei Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G. Pascale, Napoli, Italy., Gaudreau PO; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Tu D; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Sederias J; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Brown-Walker P; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Perrone F; Clinical Trials Unit, Istituto Nazionalei Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G. Pascale, Napoli, Italy., Seymour L; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Laurie SA; Ottawa Hospital Research Institute and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2024 Nov; Vol. 19 (11), pp. 1578-1579. Date of Electronic Publication: 2024 Aug 24.
Zobrazit plný text záznamu
2
Akademický článek
Oncology: What You May Have Missed in 2023.
Autor: Coschi CH; Division of Medical Oncology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada (C.H.C., L.D.)., Dodbiba L; Division of Medical Oncology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada (C.H.C., L.D.)., Guerry D; Associate Editor, Annals of Internal Medicine, and Emeritus Professor of Medicine, Perelman School of Medicine, Philadelphia, Pennsylvania (D.G.).
Publikováno v: Annals of internal medicine [Ann Intern Med] 2024 May; Vol. 177 (5_Supplement), pp. S57-S70. Date of Electronic Publication: 2024 Apr 16.
Zobrazit plný text záznamu
3
Akademický článek
Overcoming Resistance Mechanisms to Immune Checkpoint Inhibitors: Leveraging the Anti-Tumor Immune Response.
Autor: Coschi CH; Department of Oncology, McMaster University, 699 Concession Street, Hamilton, ON L8V 5C2, Canada., Juergens RA; Department of Oncology, McMaster University, 699 Concession Street, Hamilton, ON L8V 5C2, Canada.; Escarpment Cancer Research Institute, McMaster University, Hamilton, ON L8V 5C2, Canada.
Publikováno v: Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Dec 19; Vol. 31 (1), pp. 1-23. Date of Electronic Publication: 2023 Dec 19.
Zobrazit plný text záznamu
4
Akademický článek
Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171).
Autor: Piccirillo MC; Clinical Trials Unit, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G Pascale, Napoli, Italy., Chu Q; Cross Cancer Institute, Edmonton, Alberta, Canada., Bradbury P; University Health Network, Toronto, Ontario, Canada., Tu W; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Coschi CH; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Grosso F; Mesothelioma Unit (FG) & Department of Integrated Activities Research and Innovation (FU), SS. Antonio e Biagio C. Arrigo Hospital, Alessandria, Italy., Florescu M; Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada., Mencoboni M; Oncology Unit ASL 3, Villa Scassi Hospital, Genova, Italy., Goffin JR; Juravinski Cancer Centre, Ontario, Canada., Pagano M; Medical Oncology, Comprehensive Cancer Centre, AUSL Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) of Reggio Emilia, Reggio Emilia, Italy., Ciardiello F; Oncology and Hematology Unit, University of Campania 'Luigi Vanvitelli,' Naples, Italy., Cecere FL; Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituti Fisioterapici Ospitalieri (IFO) Istituto Regina Elena, Rome, Italy., Vincent M; London Regional Cancer Program, London, Ontario, Canada., Ferrara R; Thoracic Oncology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milano, Italy., Dawe DE; Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, Canada., Hao D; Tom Baker Cancer Centre and Cumming School of Medicine, Calgary, Alberta, Canada., Lee CW; British Columbia Cancer Agency, Surrey, British Columbia, Canada., Morabito A; Thoracic Oncology Unit, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G. Pascale, Napoli, Italy., Gridelli C; Oncology Unit, S. Giuseppe Moscati Hospital, Avellino, Italy., Cavanna L; Oncology and Hematology Department, USL Piacenza, Guglielmo da Saliceto Hospital, Piacenza, Italy., Iqbal M; Allan Blair Cancer Centre, Regina, Saskatchewan, Canada., Blais N; Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada., Leighl NB; University Health Network, Toronto, Ontario, Canada., Wheatley-Price P; Ottawa Hospital Research Institute and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Tsao MS; University Health Network, Toronto, Ontario, Canada., Ugo F; Mesothelioma Unit (FG) & Department of Integrated Activities Research and Innovation (FU), SS. Antonio e Biagio C. Arrigo Hospital, Alessandria, Italy., El-Osta H; Merck & Co, Inc., Rahway, New Jersey., Gargiulo P; Clinical Trials Unit, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G Pascale, Napoli, Italy., Gaudreau PO; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Tu D; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Sederias J; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Brown-Walker P; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Perrone F; Clinical Trials Unit, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G Pascale, Napoli, Italy., Seymour L; Canadian Cancer Trials Group, Kingston, Ontario, Canada. Electronic address: lseymour@ctg.queensu.ca., Laurie SA; Ottawa Hospital Research Institute and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2023 Jun; Vol. 18 (6), pp. 813-819. Date of Electronic Publication: 2023 Feb 24.
Zobrazit plný text záznamu
5
Akademický článek
Prevalence of Thyroid Transcription Factor-1 (TTF-1)-Negative Small Cell Carcinoma and Napsin A Positivity in Small Cell Carcinoma in a Cross-Sectional Study of Lung Core Biopsies.
Autor: Sayeda S; Pathology and Molecular Medicine, McMaster University, Hamilton, CAN., Naqvi A; Pathology and Molecular Medicine, McMaster University, Hamilton, CAN., Begum H; Thoracic Surgery, McMaster University, Hamilton, CAN., Juergens RA; Oncology, McMaster University, Hamilton, CAN., Finley C; Surgery, Division of Thoracic Surgery, McMaster University, Hamilton, CAN., Coschi CH; Medical Oncology, McMaster University, Hamilton, CAN., Cutz JC; Pathology and Molecular Medicine, McMaster University, Hamilton, CAN., Bonert M; Pathology and Molecular Medicine, McMaster University, Hamilton, CAN.
Publikováno v: Cureus [Cureus] 2023 Apr 01; Vol. 15 (4), pp. e37015. Date of Electronic Publication: 2023 Apr 01 (Print Publication: 2023).
Zobrazit plný text záznamu
6
Akademický článek
Understanding the Attitudes and Beliefs of Oncologists Regarding the Transitioning and Sharing of Survivorship Care.
Autor: Coschi CH; Department of Medicine, McMaster University, 1200 Main Street West, Hamilton, ON L8N 3Z5, Canada., Bainbridge D; Juravinski Hospital and Cancer Centre, Department of Oncology, McMaster University, 711 Concession Street, Hamilton, ON L8V 1C3, Canada., Sussman J; Juravinski Hospital and Cancer Centre, Department of Oncology, McMaster University, 711 Concession Street, Hamilton, ON L8V 1C3, Canada.; Hamilton Health Sciences Juravinski Cancer Centre, 699 Concession Street, Hamilton, ON L8V 5C2, Canada.
Publikováno v: Current oncology (Toronto, Ont.) [Curr Oncol] 2021 Dec 19; Vol. 28 (6), pp. 5452-5465. Date of Electronic Publication: 2021 Dec 19.
Zobrazit plný text záznamu
7
Akademický článek
The Price of Success: Immune-Related Adverse Events from Immunotherapy in Lung Cancer.
Autor: Coschi CH; Department of Oncology, McMaster University, 699 Concession Street, Hamilton, ON L8V 5C2, Canada., Juergens RA; Department of Oncology, McMaster University, 699 Concession Street, Hamilton, ON L8V 5C2, Canada.; Escarpment Cancer Research Institute, McMaster University, Hamilton, ON L8V 5C2, Canada.
Publikováno v: Current oncology (Toronto, Ont.) [Curr Oncol] 2021 Nov 02; Vol. 28 (6), pp. 4392-4407. Date of Electronic Publication: 2021 Nov 02.
Zobrazit plný text záznamu
8
Akademický článek
Neuroanatomical location of lung cancer brain metastases in 234 patients with a focus on cancer subtyping and biomarkers.
Autor: Bonert, Michael1 (AUTHOR) bonertm@mcmaster.ca, Schittenhelm, Jens2 (AUTHOR), Begum, Housne3,4 (AUTHOR), Lu, Jian-Qiang5 (AUTHOR), Swaminath, Anand6 (AUTHOR), Juergens, Rosalyn A.7 (AUTHOR), Berzins, Alison1 (AUTHOR), Cutz, Jean-Claude1 (AUTHOR), Naqvi, Asghar H.1 (AUTHOR)
Publikováno v: PLoS ONE. 11/21/2024, Vol. 19 Issue 11, p1-14. 14p.
Zobrazit plný text záznamu
9
Akademický článek
Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy.
Autor: Su, Xin1,2 (AUTHOR), Li, Jian1,2 (AUTHOR), Xu, Xiao1,2 (AUTHOR), Ye, Youbao1,2 (AUTHOR), Wang, Cailiu1,2 (AUTHOR), Pang, Guanglong1,2 (AUTHOR), Liu, Wenxiu1,2 (AUTHOR), Liu, Ang1,2 (AUTHOR), Zhao, Changchun1,2 (AUTHOR), Hao, Xiangyong2 (AUTHOR) Haoxy-2008@163.com
Publikováno v: Journal of Translational Medicine. 8/9/2024, Vol. 22 Issue 1, p1-43. 43p.
Zobrazit plný text záznamu
10
Akademický článek
Disruption of CDK-resistant chromatin association by pRB causes DNA damage, mitotic errors, and reduces Condensin II recruitment.
Autor: Ishak CA; a London Regional Cancer Program , London , Ontario , Canada.; b Department of Biochemistry , Western University , London , Ontario , Canada., Coschi CH; a London Regional Cancer Program , London , Ontario , Canada.; b Department of Biochemistry , Western University , London , Ontario , Canada., Roes MV; a London Regional Cancer Program , London , Ontario , Canada.; b Department of Biochemistry , Western University , London , Ontario , Canada., Dick FA; a London Regional Cancer Program , London , Ontario , Canada.; b Department of Biochemistry , Western University , London , Ontario , Canada.; c Children's Health Research Institute , London , Ontario , Canada.
Publikováno v: Cell cycle (Georgetown, Tex.) [Cell Cycle] 2017 Aug 03; Vol. 16 (15), pp. 1430-1439. Date of Electronic Publication: 2017 Jul 19.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje